MyFinsight
Home
Blog
About
Back
Income Statement
OCULAR THERAPEUTIX, INC (OCUL)
OCULAR THERAPEUTIX, INC (OCUL)
source: myfinsight.com
Interest income
$5,449K
(57.71%↑ Y/Y)
Change in fair value of
derivative liabilities
$689K
(207.49%↑ Y/Y)
Net loss
-$78,763K
(-16.15%↓ Y/Y)
Total other income
(expense), net
$3,346K
(2034.10%↑ Y/Y)
Interest expense
$2,792K
(-7.43%↓ Y/Y)
Loss from operations
-$82,109K
(-21.39%↓ Y/Y)
Total revenue, net
$13,475K
(0.12%↑ Y/Y)
Total costs and
operating expenses
$95,584K
(17.86%↑ Y/Y)
Research and development
$54,138K
(5.98%↑ Y/Y)
General and
administrative
$22,159K
(54.46%↑ Y/Y)
Selling and marketing
$17,276K
(25.84%↑ Y/Y)
Cost of product
revenue
$2,011K
(3.45%↑ Y/Y)
Back